AAIPharma Services facility in Wilmington, North Carolina, specializes in manufacturing oral solid dose forms to support Phase I to Phase III clinical production through commercial launch and supply.  Our facility is U.S. and E.U. compliant as well as licensed by the U.S. Drug Enforcement Agency to manufacture Schedule I-V substances and capable of handling potent compounds. We feature flexible suites and low/high shear granulation and spray/fluid bed drying capabilities to support a variety of oral solid dose products. We also are equipped to support an array of delivery methods, including immediate and extended-released tablets and capsules.

One of the benefits of our operational setup is the seamless integration of our manufacturing facilities with our on-site packaging and distribution facility.  For clinical trial supplies, we provide custom packaging, labeling and kitting – including distribution and QP services for materials destined for trials anywhere in the world.

We provide expert support for randomization and blinding studies, including placebo, comparator and crossover studies. We also provide reconciliation drug accountability and destruction service as needed.


Contact us for more information about our Oral Solid Dose Manufacturing services.